×
0.119047619047619 0.0714285714285714 0.0476190476190477 0.0476190476190477 -0.0190476190476191 -0.0428571428571428 -0.0476190476190477 -0.0952380952380952
Stockreport

ContraFect Awarded Funding from CARB-X to Support Gram-Negative Lysin Program

CONTRAFECT CORP COMMON (CFRX)  More Company Research Source: Marketwire
US:NASDAQ Investor Relations: ir.contrafect.com
PDF YONKERS, NY -- (Marketwired) -- 03/30/17 -- ContraFect Corporation (NASDAQ: CFRX), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug-resistant infectious diseases, today announced that it has been selected to receive a funding award from the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X). This award will help accelerate ContraFect's development of lysin therapeutics to treat invasive infections caused by drug resistant strains of Pseudomonas aeruginosa (P. aeruginosa), a potentially life threatening Gram-negative pathogen. Lysins are a new therapeutic class of bacteriophage-derived, recombinantly produced, antimicrobial proteins with a novel mechanism of action associated with the rapid killing of target bacteria, including antibiotic-resistant strains. "The emergence of Gram-negative bacteria which are resistant to conventional antibiot [Read more]

IMPACT SNAPSHOT EVENT TIME: CFRX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS